{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:57:54Z","timestamp":1761515874264,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.4158\/ep11142.cr","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T21:15:19Z","timestamp":1320786919000},"page":"e5-e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["H\u00fcrthle Cell Carcinoma of the Thyroid Presenting as Thyrotoxicosis"],"prefix":"10.1016","volume":"18","author":[{"given":"Harsha","family":"Karanchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale J.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP11142.CR_bb0010","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/01.rlu.0000089667.15648.e9","article-title":"Thyrotoxicosis: a rare presenting symptom of Hurthle cellcarcinoma of the thyroid","volume":"28","author":"Wong","year":"2003","journal-title":"Clin Nucl Med"},{"key":"10.4158\/EP11142.CR_bb0015","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1097-0142(19860415)57:8<1613::AID-CNCR2820570829>3.0.CO;2-3","article-title":"Hurthle cellcarcinoma of the thyroid gland. A tumor of moderate malignancy","volume":"57","author":"Har-El","year":"1986","journal-title":"Cancer"},{"key":"10.4158\/EP11142.CR_bb0020","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jcem-56-6-1131","article-title":"Impact of therapy for differentiated carcinoma of the thyroid: ananalysis of 706 cases","volume":"56","author":"Samaan","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP11142.CR_bb0025","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0025-6196(12)65621-3","article-title":"Invasive H\u00fcrthle cellcarcinoma of the thyroid: naturalhistory and management","volume":"59","author":"Watson","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"10.4158\/EP11142.CR_bb0030","first-page":"2697","article-title":"Rapid communication: predominant intracellular overexpressionof the Na(+)\/I(-) symporter (NIS) in a large sampling of thyroid cancer cases","volume":"86","author":"Doh\u00e1n","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP11142.CR_bb0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/thy.1994.4.243","article-title":"H\u00fcrthle cellneoplasms of the thyroid gland: reassessment of functionalcapacity","volume":"4","author":"Caplan","year":"1994","journal-title":"Thyroid"},{"key":"10.4158\/EP11142.CR_bb0040","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF03348449","article-title":"Biochemicaland immunohistochemicalcharacterizationof proteins in H\u00fcrthle cellcarcinoma","volume":"7","author":"De Keyser","year":"1984","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP11142.CR_bb0045","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1210\/jc.2003-030586","article-title":"Correlationbetweenthe loss of thyroglobuliniodinationand the expression of thyroid-specific proteins involved in iodine metabolism inthyroid carcinomas","volume":"88","author":"G\u00e9rard","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP11142.CR_bb0050","series-title":"Thyroidology","first-page":"63","article-title":"Thyroid cancer presenting as a hot thyroid nodule: report of a case and review of the literature","author":"Rubenfeld","year":"1988"},{"key":"10.4158\/EP11142.CR_bb0055","first-page":"349","article-title":"[Autonomy and malignancy of thyroid glad tumors. A criticalanalysis of the literature onthe existence of hyperfunctioning follicular and papillary thyroid gland carcinomas]","volume":"17","author":"Schr\u00f6der","year":"1996","journal-title":"Pathologe"},{"key":"10.4158\/EP11142.CR_bb0060","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0889-8529(18)30312-8","article-title":"Thyrotoxicosis caused by thyroid cancer","volume":"19","author":"Paul","year":"1990","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP11142.CR_bb0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hed.2890030406","article-title":"Management of thyroid nodules. II: Scanning techniques, thyroid suppressive therapy, and fine needle aspiration","volume":"3","author":"Ashcraft","year":"1981","journal-title":"Head Neck Surg"},{"key":"10.4158\/EP11142.CR_bb0070","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/BF02015798","article-title":"H\u00fcrthle cellcarcinoma in anautonomous thyroid nodule in anadolescent","volume":"25","author":"Siddiqui","year":"1995","journal-title":"Pediatr Radiol"},{"key":"10.4158\/EP11142.CR_bb0075","first-page":"735","article-title":"Detectionof anactivating mutationof the thyrotropin receptor in a case of anautonomously hyperfunctioning thyroid insular carcinoma","volume":"82","author":"Russo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP11142.CR_bb0080","first-page":"3898","article-title":"Structuralstudies of the thyrotropin receptor and Gs alpha in humanthyroid cancers: low prevalence of mutations predicts in frequent in volvement in malignant transformation","volume":"81","author":"Spambalg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP11142.CR_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/thy.1999.9.13","article-title":"A Val677 activating mutationof the thyrotropin receptor in a H\u00fcrthle cellthyroid carcinoma associated with thyrotoxicosis","volume":"9","author":"Russo","year":"1999","journal-title":"Thyroid"},{"key":"10.4158\/EP11142.CR_bb0090","series-title":"Thyrotoxicosis: Proceedings of an International Symposium","first-page":"155","article-title":"Ultrastructure of HumanThyroid in Thyrotoxicosis","author":"Heimann","year":"1967"},{"key":"10.4158\/EP11142.CR_bb0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/path.1700800219","article-title":"Histochemistry of oxidative enzyme systems in the humanthyroid, with specialreference to Askanazy cells","volume":"80","author":"Tremblay","year":"1960","journal-title":"J Pathol Bacteriol"},{"key":"10.4158\/EP11142.CR_bb0100","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/jcem-61-4-773","article-title":"Thyrotropin receptor-adenylate cyclase system in Hurthle cellneoplasms","volume":"61","author":"Clark","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP11142.CR_bb0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00000441-199531030-00003","article-title":"Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism","volume":"310","author":"Umpierrez","year":"1995","journal-title":"Am J Med Sci"},{"key":"10.4158\/EP11142.CR_bb0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11897-008-0026-9","article-title":"Thyrotoxic cardiac disease","volume":"5","author":"Dahl","year":"2008","journal-title":"Curr Heart Fail Rep"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2040895X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2040895X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/27H316KK5496X1G6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:53:50Z","timestamp":1761515630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2040895X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1530891X2040895X"],"URL":"https:\/\/doi.org\/10.4158\/ep11142.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H\u00fcrthle Cell Carcinoma of the Thyroid Presenting as Thyrotoxicosis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP11142.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}